Key facts
- SPHERA FUNDS MANAGEMENT LTD. filed SCHEDULE 13G/A for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK).
- Disclosed ownership: 4.7%.
- Date of event: 31 Dec 2025.
SPHERA FUNDS MANAGEMENT LTD. - 31 Dec 2025 SCHEDULE 13G/A Report for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK)
- Filing Manager
- SPHERA FUNDS MANAGEMENT LTD.
- Reporting Manager
- Sphera Funds Management Ltd.
- Symbol
- OTLK
- Shares outstanding
- 67,246,397 shares
- Disclosed Ownership
- 3,153,856 shares
- Ownership
- 4.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Feb 2026, 11:48:52 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 10 Apr 2025
- SEC
- View on sec.gov
Key filing fact
SPHERA FUNDS MANAGEMENT LTD. disclosed 4.7% ownership in Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK) on 31 Dec 2025.
Change
- Previous schedule filing date: 10 Apr 2025.
- Current filing was accepted on 05 Feb 2026, 11:48.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sphera Funds Management Ltd. | 4.7% | 3,153,856 | 0 | 3,153,856 | /s/ Adi Hanetz | Adi Hanetz / General Counsel | |
| Sphera Global Healthcare GP Ltd. | 4.7% | 3,153,856 | 0 | 3,153,856 | /s/ Adi Hanetz | Adi Hanetz / General Counsel | |
| Sphera Global Healthcare Management LP. | 4.7% | 3,153,856 | 0 | 3,153,856 | /s/ Adi Hanetz | Adi Hanetz / General Counsel |
CIK / CUSIP context first